Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastien Verhenne

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Hematology|November 20, 2015
ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategiesClaudia Tersteeg, Sebastien Verhenne, Elien Roose, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 2017
Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene TherapySebastien Verhenne, Nele Vandeputte, Inge Pareyn, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2010
Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndromePhilippe E Van den Steen, Nathalie Geurts, Katrien Deroost, et al.
Journal of Thrombosis and Haemostasis : JTH|June 3, 2020
von Willebrand factor increases in experimental cerebral malaria but is not essential for late-stage pathogenesis in miceSirima Kraisin, Kimberly Martinod, Linda Desender, et al.
European Journal of Medical Genetics|April 29, 2018
Improved molecular platform for the gene therapy of rare diseases by liver protein secretionMickael Quiviger, Aristeidis Giannakopoulos, Sebastien Verhenne, et al.
Blood|July 26, 2015
Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in miceSebastien Verhenne, Frederik Denorme, Sarah Libbrecht, et al.
Thrombosis and Haemostasis|October 23, 2019
A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia AVincent Muczynski, Sebastien Verhenne, Caterina Casari, et al.
Plos One|November 19, 2011
Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout miceNathalie Geurts, Erik Martens, Sebastien Verhenne, et al.
Blood|April 15, 2024
Fitusiran reduces bleeding in factor X-deficient miceSebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2019
von Willebrand factor in experimental malaria-associated acute respiratory distress syndromeSirima Kraisin, Sebastien Verhenne, Thao-Thy Pham, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Hematology|November 20, 2015
ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategiesClaudia Tersteeg, Sebastien Verhenne, Elien Roose, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 2017
Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene TherapySebastien Verhenne, Nele Vandeputte, Inge Pareyn, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2010
Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndromePhilippe E Van den Steen, Nathalie Geurts, Katrien Deroost, et al.
Journal of Thrombosis and Haemostasis : JTH|June 3, 2020
von Willebrand factor increases in experimental cerebral malaria but is not essential for late-stage pathogenesis in miceSirima Kraisin, Kimberly Martinod, Linda Desender, et al.
European Journal of Medical Genetics|April 29, 2018
Improved molecular platform for the gene therapy of rare diseases by liver protein secretionMickael Quiviger, Aristeidis Giannakopoulos, Sebastien Verhenne, et al.
Blood|July 26, 2015
Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in miceSebastien Verhenne, Frederik Denorme, Sarah Libbrecht, et al.
Thrombosis and Haemostasis|October 23, 2019
A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia AVincent Muczynski, Sebastien Verhenne, Caterina Casari, et al.
Plos One|November 19, 2011
Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout miceNathalie Geurts, Erik Martens, Sebastien Verhenne, et al.
Blood|April 15, 2024
Fitusiran reduces bleeding in factor X-deficient miceSebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2019
von Willebrand factor in experimental malaria-associated acute respiratory distress syndromeSirima Kraisin, Sebastien Verhenne, Thao-Thy Pham, et al.
Pageof 2